MedPath

Naproxcinod

Generic Name
Naproxcinod
Drug Type
Small Molecule
Chemical Formula
C18H21NO6
CAS Number
163133-43-5
Unique Ingredient Identifier
V24GR4LI3I

Overview

No overview information available.

Indication

Investigated for use/treatment in pain (acute or chronic), inflammatory disorders (unspecified), osteoarthritis, and arthritis and arthritic pain.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male
2011/07/28
NCT01404598
Phase 1
Completed
NicOx
Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide
2009/05/28
NCT00909519
Phase 1
Completed
NicOx
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
2008/05/08
NCT00674856
Phase 1
Completed
NicOx
To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension
2008/04/21
NCT00662896
Phase 1
Completed
NicOx
A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure
2008/04/21
NCT00662610
Phase 1
Completed
NicOx
A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects
2008/02/22
NCT00621881
Phase 1
Completed
NicOx
Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
2007/10/11
NCT00542555
Phase 3
Completed
NicOx
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
2007/10/10
NCT00541489
Phase 3
Completed
NicOx
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
2007/07/19
NCT00504127
Phase 3
Completed
NicOx
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
2006/10/03
NCT00383487
Phase 2
Terminated
Stanford University

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy